CYCLOHEXANEACETAMIDE, .ALPHA.-AMINO-N-(5,6-DIHYDRO-2-(1-METHYL-1H-PYRAZOL-4-YL)-6-OXO-1H-PYRROLO(4,3,2-EF)(2,3)BENZODIAZEPIN-8-YL)-, (.ALPHA.R)-
Neoplasms
PfizerSmall moleculePhase 1Dormant
C
37/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 65/ 100
Competitive context
928 Active assets in the Neoplasms cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
PANITUMUMAB Astellas Pharma Inc | Phase 2 | BBB |
GRANULOCYTE COLONY-STIMULATING FACTOR LENOGRASTIM Sanofi | Phase 4 | BB |
Relatlimab Bristol-Myers Squibb | Phase 2 | BB |
LIDOCAINE Medical College of Wisconsin | Phase 4 | BB |
Inno-206 The First Affiliated Hospital of Soochow University | Phase 2/3 | BB |
View all 50 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →